The novel cardiac myosin inhibitor aficamten improved peak oxygen uptake in symptomatic obstructive hypertrophic cardiomyopathy (HCM), the pivotal SEQUOIA-HCM trial showed. At 24 weeks, the mean ...
New research shows that exercise-based cardiac rehab offers real benefits for people with atrial fibrillation, reducing the risk of recurrence and improving mental well-being, highlighting the need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results